European Patent Office Archives

Novo Nordisk, semaglutide, opposition, weight-loss, diabetes

Generic drug companies attack Novo Nordisk's diabetes and weight-loss drug

The Boards of Appeal of the European Patent Office have revoked two patents belonging to Novo Nordisk that are important for the administration of the ...

11 October 2024 by Mathieu Klos

People & Business

Dabus, AI, Federal Court of Justice, patent application

Interview

Malte Köllner: "You can file a patent application on an AI-assisted invention"

Artificial intelligence cannot be an inventor. The Federal Court of Justice recently decided this for Germany. The court nevertheless allowed the appl ...

25 July 2024 by Mathieu Klos

Legal Commentary

Opinion

"UPC pulls ripcord on CMS in time, but proximity to the EPO is questionable"

Last Friday the UPC declared it was to cooperate with the EPO on IT matters. Most importantly, it announced the development of a new case management s ...

24 July 2024 by Mathieu Klos

Sponsored Content NPE activity in Europe

European Patent Litigation and Non-Practicing Entities: A Large and Looming Threat

PAEs from the U.S are spreading to Europe, with eight out of the top ten most active NPEs in Europe being US-based companies. One in every seven infri ...

13 June 2024 by Unified Patents, LLC

Cases

mRNA technology

Düsseldorf Regional Court can proceed with trial after EPO upholds Moderna patent

Moderna has landed an important victory at the European Patent Office. The Opposition Division granted a key mRNA patent in the face of an objection f ...

24 May 2024 by Mathieu Klos

Legal Commentary

Boards of Appeal, BoA, EPO, quality, Annual Report

Opinion

"Figures show the EPO Boards of Appeal are highly productive, but it's only half the story"

The EPO Boards of Appeal have published their Annual Report 2024 and one aspect in particular stands out: in line with the current strategy, the court ...

21 May 2024 by Mathieu Klos

Cases

EPO Enlarged Board of Appeal

EBA to consider claim construction questions in heat-not-burn dispute

In Yunnan Tobacco vs. Philip Morris, the EPO Boards of Appeal will refer key questions on claim construction to the Enlarged Board of Appeal. If the E ...

22 April 2024 by Amy Sandys

People & Business

European Patent Office

EPO Patent Index shows UPC effect as companies request unitary protection

Statistics released by the European Patent Office indicate that companies filing patents in Europe are increasingly interested in the Unitary Patent, ...

20 March 2024 by Amy Sandys

Cases

Pharmaceuticals

Akebia defends anaemia drug patents at EPO amid huge Fibrogen battle

Akebia Therapeutics has successfully defended two patents integral to a drug used to treat anaemia resulting from chronic kidney disease. The result i ...

1 March 2024 by Amy Sandys

Legal Commentary

EPO, Administrative Council, patent quality

European Patent Office

EPO staff petition Administrative Council to improve HR and patent quality

For weeks, some European Patent Office staff have been calling on management to reduce work pressure and improve quality in the granting of patents. N ...

28 February 2024 by Mathieu Klos

Cases

Biotechnology

EPO revokes two more DNA-sequencing patents despite Illumina appeal

The EPO Boards of Appeal have confirmed the revocation of two more Illumina patents concerning DNA-sequencing technology. The same boards also issued ...

13 February 2024 by Amy Sandys

People & Business

European Patent Office

EPO reduces fees for micro-entities to boost access to European patent system

The European Patent Office has announced the introduction of a new fee-reduction scheme for micro-entities. Announced on 31 January, the scheme aims t ...

2 February 2024 by Amy Sandys

Comparison of opposition proceedings at the EPO and revocation actions at the UPC – advantages and disadvantages

Since the introduction of the Unified Patent Court (UPC) in June 2023, a new system for central attacking the validity of and thereby to nullify a Eur ...

30 January 2024 by Prüfer and Partner mbB

Cases

Top ten most-read articles 2023, patent, JUVE Patent

Year in review 2023

EPO revokes Moderna patent in vaccine dispute with BioNTech

In the pan-European dispute between Moderna and BioNTech over mRNA patents, the patent holder Moderna has now suffered a defeat at the European Patent ...

21 November 2023 by Konstanze Richter

Name	Borlabs Cookie
Provider	Owner of this website, Imprint
Purpose	Saves the visitors preferences selected in the Cookie Box of Borlabs Cookie.
Cookie Name	borlabs-cookie
Cookie Expiry	1 Year

Name	Google Tag Manager
Provider	Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland
Purpose	Cookie by Google used to control advanced script and event handling.
Privacy Policy	https://policies.google.com/privacy?hl=en
Cookie Name	_ga,_gat,_gid
Cookie Expiry	1 Year

Accept	Google Analytics
Name	Google Analytics
Provider	Google LLC
Purpose	Cookie by Google used for website analytics. Generates statistical data on how the visitor uses the website.
Privacy Policy	https://policies.google.com/privacy?hl=en
Cookie Name	_ga,_gat,_gid
Cookie Expiry	1 Year

Accept	Google Analytics 4
Name	Google Analytics 4
Provider	Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland
Purpose	Cookie by Google used for website analytics. Generates statistical data on how the visitor uses the website.
Privacy Policy	https://policies.google.com/privacy?hl=en
Cookie Name	_ga,_gat,_gid
Cookie Expiry	2 Months

Accept	Hotjar
Name	Hotjar
Provider	Hotjar Ltd., Dragonara Business Centre, 5th Floor, Dragonara Road, Paceville St Julian's STJ 3141 Malta
Purpose	Hotjar is an user behavior analytic tool by Hotjar Ltd.. We use Hotjar to understand how users interact with our website.
Privacy Policy	https://www.hotjar.com/legal/policies/privacy/
Host(s)	*.hotjar.com
Cookie Name	_hjClosedSurveyInvites, _hjDonePolls, _hjMinimizedPolls, _hjDoneTestersWidgets, _hjIncludedInSample, _hjShownFeedbackMessage, _hjid, _hjRecordingLastActivity, hjTLDTest, _hjUserAttributesHash, _hjCachedUserAttributes, _hjLocalStorageTest, _hjptid
Cookie Expiry	Session / 1 Year

Accept	Facebook
Name	Facebook
Provider	Meta Platforms Ireland Limited, 4 Grand Canal Square, Dublin 2, Ireland
Purpose	Used to unblock Facebook content.
Privacy Policy	https://www.facebook.com/privacy/explanation
Host(s)	.facebook.com

Accept	OpenStreetMap
Name	OpenStreetMap
Provider	Openstreetmap Foundation, St John’s Innovation Centre, Cowley Road, Cambridge CB4 0WS, United Kingdom
Purpose	Used to unblock OpenStreetMap content.
Privacy Policy	https://wiki.osmfoundation.org/wiki/Privacy_Policy
Host(s)	.openstreetmap.org
Cookie Name	_osm_location, _osm_session, _osm_totp_token, _osm_welcome, _pk_id., _pk_ref., _pk_ses., qos_token
Cookie Expiry	1-10 Years

Accept	Twitter
Name	Twitter
Provider	Twitter International Company, One Cumberland Place, Fenian Street, Dublin 2, D02 AX07, Ireland
Purpose	Used to unblock Twitter content.
Privacy Policy	https://twitter.com/privacy
Host(s)	.twimg.com, .twitter.com
Cookie Name	__widgetsettings, local_storage_support_test
Cookie Expiry	Unlimited

Accept	Vimeo
Name	Vimeo
Provider	Vimeo Inc., 555 West 18th Street, New York, New York 10011, USA
Purpose	Used to unblock Vimeo content.
Privacy Policy	https://vimeo.com/privacy
Host(s)	player.vimeo.com
Cookie Name	vuid
Cookie Expiry	2 Years

European Patent Office

Generic drug companies attack Novo Nordisk's diabetes and weight-loss drug

Malte Köllner: "You can file a patent application on an AI-assisted invention"

"UPC pulls ripcord on CMS in time, but proximity to the EPO is questionable"

European Patent Litigation and Non-Practicing Entities: A Large and Looming Threat

Düsseldorf Regional Court can proceed with trial after EPO upholds Moderna patent

"Figures show the EPO Boards of Appeal are highly productive, but it's only half the story"

EBA to consider claim construction questions in heat-not-burn dispute

EPO Patent Index shows UPC effect as companies request unitary protection

Akebia defends anaemia drug patents at EPO amid huge Fibrogen battle

EPO staff petition Administrative Council to improve HR and patent quality

EPO revokes two more DNA-sequencing patents despite Illumina appeal

EPO reduces fees for micro-entities to boost access to European patent system

Comparison of opposition proceedings at the EPO and revocation actions at the UPC – advantages and disadvantages

Top 10 most-read articles of the year 2023

EPO revokes Moderna patent in vaccine dispute with BioNTech